The discovery of the STImS framework suggests that the 'one size fits all' approach to treating systemic inflammation is no longer sufficient for modern critical care. Sepsis remains a formidable challenge, claiming millions of lives annually through a process where the immune system inadvertently
The SLICeVLP system decouples guide RNA delivery from Cas9 protein delivery to enable large-scale pooled CRISPR screening in primary human macrophages for the first time. This technological leap addresses a longstanding bottleneck in the field of immunotherapy, where the focus has historically
The shift toward precision medicine requires a continuous assessment of risk that updates dynamically as new follow-up scans and blood tests become available. This ongoing demand for agility is driving a fundamental transformation in lung cancer management, moving the field away from isolated
The biological monopoly held by the standard twenty amino acids has finally met its match in a laboratory environment that prioritizes chemical versatility over the stubborn requirements of cellular survival. For decades, the progress of synthetic biology was tethered to the growth cycles and
Respiratory motion is not just a byproduct of breathing but a fundamental driver of how the human immune system responds to viral threats. For decades, the medical community struggled to understand why laboratory experiments involving lung infections often failed to match the complex reality of a
In addition to the recent NCI renewal, the UC Davis Medical Center has maintained its ranking as the top hospital in the Sacramento area for fifteen consecutive years according to national reports. This sustained excellence reached a new milestone today as the National Cancer Institute officially
